Coronavirus

Compared with COVID-19 vaccination alone, recent study findings show health care workers who received both a COVID-19 booster and influenza vaccinations did not have lower immune response or more frequent adverse events.

The CDC emphasized the need for protein-based vaccine options in endorsing a vote by the Advisory Committee on Immunization Practices for the universal recommendation of the 2023-2024 monovalent, XBB containing COVID-19 vaccines.

Failing to protect the elderly from disease has consequences beyond nursing homes.

Senate Bill 219 will also allow pharmacists to independently administer influenza and COVID-19 tests waived by the clinical laboratory improvement amendments.

FDA grants updated Moderna and Pfizer-BioNTech COVID-19 vaccines with emergency use authorization to target currently circulating variants of the virus.

With the emergence of BA.2.86, and the growing prevalence of EG.5 and FL1.5.1, there is a need for updated vaccines against COVID-19 to help decrease severe disease and hospitalizations.

Understanding the virus protein’s insertion mechanisms can be useful in creating new COVID-19 vaccine targets.

AI is revolutionizing pharmacy practice by improving medication management, streamlining workflow, and enhancing patient safety and outcomes.

Although the pandemic has negatively influenced the care that patients with cardiovascular conditions receive, the study authors found that there were not significant inequities regarding patients’ race.

In a previous trial, DARE-19, investigators reported that the SGLT2 inhibitor dapagliflozin did not benefit patients with COVID-19 who had cardiometabolic risk factors.

Despite study findings showing that 1 in 5 patients hospitalized for COVID-19 developed persistent high blood pressure, many had underlying risk factors.

Technology and regulations can revolutionize drug manufacturing and ensure a stable supply of medications.

This technique may be applied to transdermal applications, such as shot-free vaccines.

Investigators determined that there needs to be an evaluation of harm caused by pharmacy professionals who are in unique positions on social media, propagating misinformation about COVID-19, vaccines, treatment, masks, and other conspiracy theories.

The approach allows investigators to assess post-vaccine response in immunocompromised patients who have received antibody prophylaxis.

A COVID-19 booster dose increased both maternal and cord blood binding and neutralizing antibody levels against virus strains, including Omicron BA.1.

A bit of preparation can set children up for success and reduce the stress of this busy time.

Study results showed no significant association between those who bite their nails and SARS-CoV-2 infection, in addition to a lower rate of infection for those who wear glasses compared to those who don’t wear glasses.

Compared to the BNT162b2 vaccine, the mRNA-1273 vaccine was associated with a lower risk of adverse events, which investigators speculate was due to interrelated safety and efficacy.

Wastewater surveillance could be the most consistent way to measure COVID-19 across US counties, a recent study indicates.

The approved assay can differentiate between infection of COVID-19, influenza, or respiratory syncytial virus, minimizing the need for multiple tests or physician visits.

The health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.

The common diabetes drug could mediate hyperglycemia, which is caused when SARS-CoV-2 infects hepatocytes.

Community-based pharmacy services are reaching new heights as pharmacists and pharmacy technicians are able to have a larger impact on patient care than ever before.

Further work is necessary to monitor and develop understanding of recovery for individuals with ongoing COVID-19 symptoms.

With the end of the national public health emergency for COVID-19 in May 2023, what can be expected as we look ahead to the 2023-2024 influenza season and beyond?

Study among the first to examine delayed or missed pediatric preventative care during COVID-19 that considers determinants, race, and ethnic group, according to the authors.

Proof-of-concept device will be able to detect SARS-CoV-2 within minutes.

The effectiveness of influenza vaccines varies each season and is determined by the circulating influenza virus subtype(s) and the extent to which there is an antigenic match in the vaccines to the circulating virus subtypes.

Using artificial intelligence to sort and respond to patient queries could streamline processes and alleviate provider burnout.